Monday 10th March, Mutlu Dogruel, VP of AI at Cresset, hosted a 30-minute keynote presentation at the AI in Drug Discovery Conference in London. The conference brought together leaders at the forefront of AI innovation, leading big pharma and innovate biotech companies with technology providers.
At Cresset, we’re dedicated to empowering researchers with tools that not only enhance productivity but also simplify complex processes. That’s why we’re excited to introduce new AI-powered assistants within Flare™, our flagship computational chemistry platform. These assistants are designed to elevate the user experience, making advanced computational tasks more accessible through low-code and no-code solutions.
During the AI in Drug Discovery conference, Mutlu revealed how our latest advancements in drug design software integrate AI to streamline workflows, making both creation and execution more efficient. With the introduction of Cresset AI chatbots, users can easily automate code writing and get assistance with queries, simplifying drug design tasks. Additionally, AI-driven summary reports and data analysis in generative chemistry provide deeper insights, empowering users to make more informed decisions.
Mutlu commented: “Attending the ‘AI in Drug Discovery’ event was an inspiring experience where I had the opportunity to present ‘AI at Cresset: Enhancing Efficiency, Empowering Decisions’. The enthusiastic feedback we received affirms our approach at Cresset – leveraging AI to drive meaningful change and innovation in drug discovery. We’re excited to continue pushing boundaries and leading the way in AI-enhanced solutions. For a sneak peek into what’s coming, I encourage you to read our recent article in GEN magazine.”
Contact us to test our AI bots
